Gold prices edge higher on raised Fed rate cut hopes
Bradley Herring, the Chief Financial Officer of Enfusion, Inc. (NYSE:ENFN), recently sold 24,443 shares of the company’s Class A common stock. The shares were sold at a weighted average price of $10.61, resulting in a total transaction value of approximately $259,340. Following this transaction, Herring retains ownership of 270,503 shares. The sale was conducted to cover tax withholding obligations and was not a discretionary trade by Herring. According to InvestingPro, the company maintains a GOOD overall financial health score, with 13 additional key insights available for subscribers.
In other recent news, Enfusion Inc. reported a successful third quarter in 2024, with a 15% increase in year-over-year revenue to $51.2 million and an adjusted EBITDA of $11.1 million, representing a 21.8% margin. The company's annual recurring revenue (ARR) surpassed $200 million, marking a 14% year-over-year increase. The company also signed 38 new clients, totaling 894, and reported an average total value (ATV) of $229,000, up 5.7% year-over-year.
Revenue growth was notable across all regions, with 17% in the Americas, 22% in EMEA, and 6% in Asia-Pacific. Enfusion is tightening its full-year revenue guidance to between $202 million and $205 million, with EBITDA guidance at $41 million to $45 million.
Management remains confident in achieving its medium-term revenue growth target of 20% to 22% from 2025 to 2027. The company expects to maintain a consistent margin with EBITDA guidance refined to $41 million to $45 million. These are recent developments that indicate the company's strategic focus on product innovation and market expansion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.